NetworkNewsBreaks Archive - Page 1019 of 2228

ThursdayNov 11, 2021 2:00 pm

NetworkNewsBreaks – Computer Task Group, Inc. (NASDAQ: CTG) Featured in Research Note from Sidoti

Earnings Release Computer Task Group (NASDAQ: CTG) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “CTG’s Mostly In-Line 3Q:21 Results Showcase Greater Traction In High-Margin IT Solutions Work; Reinstated Guidance For 4Q:21 Was Upbeat, Reflects Large Project Win; Maintain $14 Price Target.” Click here to access the full report. About Computer Task Group, Inc. CTG is a leading provider of digital transformation solutions and services that accelerate clients’ project momentum and achievement of their desired IT and business outcomes. We have earned a reputation as a reliable, results-driven partner focused…

ThursdayNov 11, 2021 1:37 pm

NetworkNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Expands Commercial Program to Add Another Leading Turkish Packing House

Save Foods (NASDAQ: SVFD), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced that Uçak Kardeşler, a leading Turkish packing house, is joining Save Foods’ commercial program. According to the update, the packing house will launch a large commercial-scale pilot to ensure the product’s seamless implementation and efficacy as the first step in the program. “In our recent press release dated Nov. 8, I mentioned our ongoing efforts to include additional leading Turkish packing houses to join our commercial program,”…

ThursdayNov 11, 2021 1:31 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Cannabinoid Science

Flora Growth Corp. (NASDAQ: FLGC) recently announced the next stage of its development with the creation of Flora Pharma and the execution of an agreement to begin scientific clinical trials globally. Flora Pharma’s formation follows the acknowledgment and commitment by the management team and board of directors to move ahead with applied research initiatives in medical cannabis in order to become a leader in the discovery, development, manufacturing and commercialization of novel, phytocannabinoid-based prescription medicines and nutraceutical products to address a broad range of diseases. The company also signed an agreement to begin scientific clinical trials on the use of…

ThursdayNov 11, 2021 1:22 pm

NetworkNewsBreaks – Roth Capital Partners LLC’s AgTech Event to Feature 1-on-1s, Engaging Industry Panels

Roth Capital Partners, a full-service investment bank renowned for serving emerging growth companies, today announced the agenda for the Inaugural AgTech Answers Virtual Event. This year's conference, set to take place Nov. 16-18, 2021, will consist of virtual one-on-one / small group meetings and two industry panels. The forum will feature two engaging discussions, including, Capital Perspectives on AgTech and Changemakers in Agriculture. In addition, Roth’s AgTech Senior Research Analysts Brian Wright and Gerry Sweeney selected more than 25 companies that will take one-on-one meetings throughout the day. According to the update, these will consist of 40-minute management-investor video meetings…

ThursdayNov 11, 2021 1:05 pm

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Issues Update on Underwritten Public Offering of American Depositary Shares

AnPac Bio (NASDAQ: ANPC) today issued a correction to its press release dated Nov. 9, 2021, regarding the pricing of its underwritten public offering of American Depositary Shares (“ADSs”). According to the update, the original release referenced the dollar size of the offering and the number of ADSs being sold to include the exercise of the over-allotment option rather than just the base offering. The expected closing date has been updated to Nov. 15, 2021, for the offering of 1,132,111 ADSs, each at a public offering price of $2.22, for approximately $2.5 million in gross proceeds to the company. In connection with…

ThursdayNov 11, 2021 1:01 pm

NetworkNewsBreaks – FingerMotion Inc.’s (FNGR) Q2 Results Represent ‘Transition to Greater Profitability’

FingerMotion (OTCQX: FNGR), a communications and big data technology platform builder, recently released its Q2 results. “The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25% year-over-year quarterly growth in its short and multimedia messaging (‘SMS’ and ‘MMS’) business revenue of $0.73 million,” reads a recent article. According to CEO Martin Shen, the company is seeing unabated growth with SMS texting due to its optimized prepayments of bulk inventory purchases — the subscription plan and mobile phone sales contributed to this growth. FNGR is also seeing strong demand in SMS from its corporate clientele. “Despite the positive…

ThursdayNov 11, 2021 12:51 pm

NetworkNewsBreaks – illimity Announces Strong Continued Growth in Q3 2021

illimity Bank S.p.A. (“illimity” or the “Bank”) has announced approval of the illimity Group’s results at Sept. 30, 2021. According to the update, illimity reported continued solid financial and operating performance in the third quarter of 2021. This includes a net profit of 18.8 million euro (a 26% quarter-over-quarter increase from 14.9 million euro in the second quarter of 2021, and a 98% year-over-year increase from 9.5 million euro in the third quarter of 2020). This brings the net result for the first nine months of the year to 46.2 million euro, up by 90% over the corresponding period in…

ThursdayNov 11, 2021 12:47 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Partnerships to Facilitate TRP-8803’s Advancement

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently announced a collaboration with researchers at the University of Wisconsin-Madison as part of preparations toward planned phase 2b studies. Under the partnership, Dr. Paul Hutson, PharmD, and Dr. Christopher Nicholas, Ph.D., will support clinical pharmacology studies for TRP-8803, Tryp’s proprietary drug formulation with a novel route of administration. Once completed, the studies will provide additional regulatory support for TRP-8803. The pair will also serve as investigators on a clinical pharmacology study to evaluate the safety and pharmacokinetics of TRP-8803. “This partnership is the latest in a series of collaborations with scholars, institutions and…

ThursdayNov 11, 2021 12:32 pm

NetworkNewsBreaks – Why Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is guided by the vision to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. “Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the city of Los Angeles and the state of California, and it is now working toward taking operational control of each license,” reads a recent article. Its brand portfolio includes NUGS, the NUGS Farm North and MDRN Tree. NUGS provides emerging…

ThursdayNov 11, 2021 12:31 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of its second U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. Entitled “Ultrahigh Pressure Compact Valve with Throttling Capability,” the new patent brings the company’s intellectual property (“IP”) estate to a total of seven UST patents (two in the U.S.) and 30 pressure-based patents worldwide. “The conversion of a coarser emulsion into a high-quality nanoemulsion with ultra-low droplet size is made possible by intense…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks